Allakos Croissance future
Future contrôle des critères 0/6
Allakos is forecast to grow earnings and revenue by 17.4% and 91.7% per annum respectively while EPS is expected to grow by 32.2% per annum.
Informations clés
17.4%
Taux de croissance des bénéfices
32.2%
Taux de croissance du BPA
Biotechs croissance des bénéfices | 27.1% |
Taux de croissance des recettes | 91.7% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 26 Sep 2024 |
Mises à jour récentes de la croissance future
Recent updates
We Think Allakos (NASDAQ:ALLK) Needs To Drive Business Growth Carefully
Aug 27We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate
May 05We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate
Dec 01Companies Like Allakos (NASDAQ:ALLK) Are In A Position To Invest In Growth
Aug 03Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely
Apr 20Is Allakos Inc. (NASDAQ:ALLK) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 04Allakos: Potential For Comeback With Lirentelimab With 2 Indications
Oct 18Allakos prices ~$150M underwritten offering
Sep 19Allakos falls as lead asset offers mixed results in late-stage trial
Sep 09Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely
Aug 06Will Allakos (NASDAQ:ALLK) Spend Its Cash Wisely?
Apr 22Allakos: Sad End To A Promising Asset
Dec 23We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely
Dec 01We Think Allakos (NASDAQ:ALLK) Can Afford To Drive Business Growth
Aug 16Allakos: Upcoming Phase 3 Data Makes The Stock Interesting
Aug 06Allakos provides lirentelimab clinical trial enrollment updates, names new CMO
Jun 07We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely
May 02Have Allakos Inc. (NASDAQ:ALLK) Insiders Been Selling Their Stock?
Mar 10Allakos Inc. (NASDAQ:ALLK) Insiders Have Been Selling
Jan 28We're Interested To See How Allakos (NASDAQ:ALLK) Uses Its Cash Hoard To Grow
Dec 07Allakos EPS misses by $0.02
Nov 09Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | N/A | -95 | N/A | -67 | 4 |
12/31/2025 | N/A | -70 | N/A | -20 | 5 |
12/31/2024 | N/A | -133 | N/A | -42 | 5 |
6/30/2024 | N/A | -206 | -103 | -103 | N/A |
3/31/2024 | N/A | -214 | -119 | -119 | N/A |
12/31/2023 | N/A | -186 | -117 | -116 | N/A |
9/30/2023 | N/A | -166 | -140 | -139 | N/A |
6/30/2023 | N/A | -151 | -139 | -136 | N/A |
3/31/2023 | N/A | -165 | -142 | -136 | N/A |
12/31/2022 | N/A | -320 | -288 | -280 | N/A |
9/30/2022 | N/A | -371 | -322 | -299 | N/A |
6/30/2022 | N/A | -403 | -350 | -319 | N/A |
3/31/2022 | N/A | -411 | -371 | -336 | N/A |
12/31/2021 | N/A | -270 | -241 | -208 | N/A |
9/30/2021 | N/A | -220 | -195 | -177 | N/A |
6/30/2021 | N/A | -199 | -174 | -166 | N/A |
3/31/2021 | N/A | -181 | -143 | -142 | N/A |
12/31/2020 | N/A | -153 | -115 | -114 | N/A |
9/30/2020 | N/A | -134 | -99 | -99 | N/A |
6/30/2020 | N/A | -113 | -79 | -79 | N/A |
3/31/2020 | N/A | -93 | -69 | -68 | N/A |
12/31/2019 | N/A | -85 | -64 | -63 | N/A |
9/30/2019 | N/A | -75 | -60 | -57 | N/A |
6/30/2019 | N/A | -65 | -55 | -49 | N/A |
3/31/2019 | N/A | -55 | -49 | -42 | N/A |
12/31/2018 | N/A | -44 | -45 | -38 | N/A |
9/30/2018 | N/A | -37 | -38 | -33 | N/A |
6/30/2018 | N/A | -32 | -32 | -30 | N/A |
3/31/2018 | N/A | -27 | N/A | -26 | N/A |
12/31/2017 | N/A | -24 | N/A | -23 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: ALLK is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: ALLK is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: ALLK is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: ALLK is forecast to have no revenue next year.
Croissance élevée des revenus: ALLK is forecast to have no revenue next year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if ALLK's Return on Equity is forecast to be high in 3 years time